Literature DB >> 3181208

Excessive growth in a child with craniopharyngioma and growth hormone deficiency.

J M Wit1, A Schuitema-Dijkstra, S van Buul-Offers, F Opmeer, J L Van den Brande.   

Abstract

In a 5-year-old boy presenting with clumsiness and excessive growth, a large craniopharyngioma was diagnosed. Biochemically, there was a deficiency of growth hormone, a hypothalamic hypothyroidism and hypocorticalism, a thyroxine binding globulin elevation, an abnormal gonadotropin secretion and a mild hyperprolactinaemia. After removal of the tumour growth stopped almost completely. Plasma insulin-like growth factor (IGF)-I was in the lower normal range. Plasma IGF-II decreased after tumour removal. It is speculated that the tumour produced a growth factor causing excessive growth.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181208     DOI: 10.1007/bf00442487

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  The growth of cultured rabbit articular chondrocytes is stimulated by pituitary growth factors but not by purified human growth hormone or ovine prolactin.

Authors:  K L Jones; J F Villela; U J Lewis
Journal:  Endocrinology       Date:  1986-06       Impact factor: 4.736

3.  An improved technique for measuring somatomedin activity in vitro.

Authors:  J L van den Brande; M V Du Caju
Journal:  Acta Endocrinol (Copenh)       Date:  1974-02

4.  Chondrocyte growth factor from the human pituitary gland.

Authors:  S Kasper; I G Worsley; J M Rowe; R P Shiu; H G Friesen
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

5.  Isolation and partial molecular characterization of pituitary fibroblast growth factor.

Authors:  P Böhlen; A Baird; F Esch; N Ling; D Gospodarowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Growth without growth hormone: evidence for a potent circulating human growth factor.

Authors:  M E Geffner; B M Lippe; N Bersch; A Van Herle; S A Kaplan; M J Elders; D W Golde
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

7.  Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region.

Authors:  A Silbergeld; A Litwin; S Bruchis; I Varsano; Z Laron
Journal:  Clin Endocrinol (Oxf)       Date:  1986-07       Impact factor: 3.478

8.  A unique growth factor in patients with acromegaloidism.

Authors:  M W Ashcraft; P I Hartzband; A J Van Herle; N Bersch; D W Golde
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

9.  Human pituitary tissue secretes a potent growth factor for chondrocyte proliferation.

Authors:  S Kasper; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

10.  Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth.

Authors:  R M Bala; J Lopatka; A Leung; E McCoy; R G McArthur
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

View more
  1 in total

Review 1.  Endocrine manifestations of craniopharyngioma.

Authors:  Isil Halac; Donald Zimmerman
Journal:  Childs Nerv Syst       Date:  2005-07-27       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.